• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向肿瘤纤维化基质和血管生成血管来调节肿瘤免疫以治疗肺癌

Modulating Tumor Immunity by Targeting Tumor Fibrotic Stroma and Angiogenic Vessels for Lung Cancer Treatment.

作者信息

Yuan Yi, Mishra Falguni, Li Bin, Peng Guangda, Chan Payton, Yang Jenny, Liu Zhiren

机构信息

Department of Biology, Georgia State University, Atlanta, GA 30303, USA.

Department of Chemistry, Georgia State University, Atlanta, GA 30303, USA.

出版信息

Cancers (Basel). 2024 Jul 8;16(13):2483. doi: 10.3390/cancers16132483.

DOI:10.3390/cancers16132483
PMID:39001545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11240634/
Abstract

Fibrotic stroma and angiogenic tumor vessels play an important role in modulating tumor immunity. We previously reported a rationally designed protein (ProAgio) that targets integrin αβ at a novel site. ProAgio induces the apoptosis of cells that express high levels of the integrin. Both activated cancer-associated fibroblasts (CAFs) and angiogenic endothelial cells (aECs) in tumors express high levels of integrin αβ. ProAgio simultaneously and specifically induces apoptosis in CAFs and aECs in tumors. We provide evidence here that the depletion of CAFs and the elimination of leaky tumor angiogenic vessels by ProAgio alter tumor immunity. ProAgio reduces CD Treg and Myeloid-derived suppressor cells (MDSCs), increases CD T-cells, and increases the M1/M2 macrophage ratio in the tumor. The depletion of dense fibrotic stroma (CAFs) by ProAgio decreases the () levels in the stroma areas surrounding the tumors, and thus strongly increases the delivery of anti-PDL-1 antibody to the target cancer cells. The impact of ProAgio on tumor immunity provides strong synergistical effects of checkpoint inhibitors on lung cancer treatment.

摘要

纤维化基质和肿瘤血管生成在调节肿瘤免疫中发挥重要作用。我们之前报道了一种经过合理设计的蛋白质(ProAgio),它能在一个新位点靶向整合素αβ。ProAgio可诱导高表达该整合素的细胞凋亡。肿瘤中活化的癌症相关成纤维细胞(CAFs)和血管生成性内皮细胞(aECs)均高表达整合素αβ。ProAgio能同时特异性地诱导肿瘤中的CAFs和aECs凋亡。我们在此提供证据表明,ProAgio对CAFs的消耗以及对肿瘤血管生成渗漏血管的消除改变了肿瘤免疫。ProAgio可减少CD4+调节性T细胞(Treg)和髓源性抑制细胞(MDSCs),增加CD4+T细胞,并提高肿瘤中M1/M2巨噬细胞比例。ProAgio对致密纤维化基质(CAFs)的消耗降低了肿瘤周围基质区域的()水平,从而显著增加了抗程序性死亡受体1(PDL-1)抗体向靶癌细胞的递送。ProAgio对肿瘤免疫的影响为检查点抑制剂在肺癌治疗中提供了强大的协同效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/0bc6ee772365/cancers-16-02483-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/c36b8643310d/cancers-16-02483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/8be3a7401eb8/cancers-16-02483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/82f376a25703/cancers-16-02483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/3536c9d4b3cc/cancers-16-02483-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/0bc6ee772365/cancers-16-02483-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/c36b8643310d/cancers-16-02483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/8be3a7401eb8/cancers-16-02483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/82f376a25703/cancers-16-02483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/3536c9d4b3cc/cancers-16-02483-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/11240634/0bc6ee772365/cancers-16-02483-g005.jpg

相似文献

1
Modulating Tumor Immunity by Targeting Tumor Fibrotic Stroma and Angiogenic Vessels for Lung Cancer Treatment.通过靶向肿瘤纤维化基质和血管生成血管来调节肿瘤免疫以治疗肺癌
Cancers (Basel). 2024 Jul 8;16(13):2483. doi: 10.3390/cancers16132483.
2
Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC.联合靶向肿瘤相关成纤维细胞和血管生成血管作为三阴性乳腺癌的治疗方法。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20200712.
3
Modulation of Cancer-Associated Fibrotic Stroma by An Integrin αβ Targeting Protein for Pancreatic Cancer Treatment.靶向整合素 αβ 的蛋白治疗胰腺癌对癌相关纤维性基质的调控作用。
Cell Mol Gastroenterol Hepatol. 2021;11(1):161-179. doi: 10.1016/j.jcmgh.2020.08.004. Epub 2020 Aug 15.
4
Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment.通过合理设计的蛋白质靶向整合素 αvβ3 治疗慢性肝病。
Commun Biol. 2021 Sep 16;4(1):1087. doi: 10.1038/s42003-021-02611-2.
5
Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition.靶向成纤维细胞整合素 α5 通过影响细胞外基质沉积增强结直肠癌对 PD-L1 阻断的反应。
J Immunother Cancer. 2023 Dec 1;11(12):e007447. doi: 10.1136/jitc-2023-007447.
6
Rational design of a protein that binds integrin αvβ3 outside the ligand binding site.在配体结合位点之外设计与整合素 αvβ3 结合的蛋白质。
Nat Commun. 2016 May 31;7:11675. doi: 10.1038/ncomms11675.
7
IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration.基于 IR-780 染料的靶向肿瘤相关成纤维细胞通过增加肿瘤内 T 淋巴细胞浸润来改善癌症免疫治疗。
Curr Cancer Drug Targets. 2024;24(6):642-653. doi: 10.2174/0115680096261142231018104854.
8
Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment.利用一种合理设计的蛋白质治疗非酒精性脂肪性肝炎和酒精性肝炎:耗竭活化的肝星状细胞和毛细血管化的肝窦内皮细胞。
Int J Mol Sci. 2024 Jul 6;25(13):7447. doi: 10.3390/ijms25137447.
9
Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.工程化的外泌体样纳米囊泡通过重编程肿瘤微环境和促进肿瘤铁死亡来抑制肿瘤生长。
Acta Biomater. 2021 Nov;135:567-581. doi: 10.1016/j.actbio.2021.09.003. Epub 2021 Sep 8.
10
Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.通过全面重塑肿瘤微环境,同步靶向递送 TGF-β siRNA 至基质细胞和肿瘤细胞可引发针对三阴性乳腺癌的强烈抗肿瘤免疫。
Biomaterials. 2023 Oct;301:122253. doi: 10.1016/j.biomaterials.2023.122253. Epub 2023 Jul 25.

引用本文的文献

1
Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity.细胞外丙酮酸激酶M2通过调节巨噬细胞极性来调控癌症免疫。
Cancer Immunol Immunother. 2025 May 9;74(7):195. doi: 10.1007/s00262-025-04050-y.
2
Promotion Mechanisms of Stromal Cell-Mediated Lung Cancer Development Within Tumor Microenvironment.肿瘤微环境中基质细胞介导肺癌发展的促进机制
Cancer Manag Res. 2025 Feb 11;17:249-266. doi: 10.2147/CMAR.S505549. eCollection 2025.

本文引用的文献

1
PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.表达 PD-L1 的肿瘤相关成纤维细胞诱导肿瘤免疫抑制,并导致食管癌不良临床结局。
Cancer Immunol Immunother. 2023 Nov;72(11):3787-3802. doi: 10.1007/s00262-023-03531-2. Epub 2023 Sep 5.
2
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges.免疫检查点抑制治疗可切除非小细胞肺癌:机遇与挑战。
Nat Rev Clin Oncol. 2023 Oct;20(10):664-677. doi: 10.1038/s41571-023-00794-7. Epub 2023 Jul 24.
3
Lung cancer immunotherapy: progress, pitfalls, and promises.
肺癌免疫疗法:进展、陷阱和前景。
Mol Cancer. 2023 Feb 21;22(1):40. doi: 10.1186/s12943-023-01740-y.
4
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors.肺癌免疫疗法:超越常见免疫检查点抑制剂
Cancers (Basel). 2022 Dec 13;14(24):6145. doi: 10.3390/cancers14246145.
5
Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade.肿瘤微环境中肿瘤血管生成和免疫抑制相互作用的调控:抗血管生成与免疫检查点阻断联合治疗的新视角。
Front Immunol. 2022 Nov 10;13:1035323. doi: 10.3389/fimmu.2022.1035323. eCollection 2022.
6
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.缺氧诱导因子:缺氧肿瘤免疫逃逸的主调控因子。
J Hematol Oncol. 2022 Jun 3;15(1):77. doi: 10.1186/s13045-022-01292-6.
7
Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.非小细胞肺癌中的癌相关成纤维细胞:从分子机制到临床意义。
Int J Cancer. 2022 Oct 15;151(8):1195-1215. doi: 10.1002/ijc.34127. Epub 2022 Jun 8.
8
Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity.癌症相关成纤维细胞——有效抗肿瘤 T 细胞免疫的障碍。
Front Immunol. 2022 Apr 11;13:887380. doi: 10.3389/fimmu.2022.887380. eCollection 2022.
9
Immunotherapy in Lung Cancer: Current Landscape and Future Directions.肺癌的免疫治疗:现状与未来方向。
Front Immunol. 2022 Feb 9;13:823618. doi: 10.3389/fimmu.2022.823618. eCollection 2022.
10
Extracellular PKM2 facilitates organ-tissue fibrosis progression.细胞外丙酮酸激酶M2促进器官组织纤维化进展。
iScience. 2021 Sep 25;24(10):103165. doi: 10.1016/j.isci.2021.103165. eCollection 2021 Oct 22.